Portfolio Management Services (PMS)
Compare Schemes

NARNOLIA FUSION OPPORTUNITY STRATEGY vs Polaris Human Plus Machine Converged Equity Strategy

NARNOLIA FUSION OPPORTUNITY STRATEGY
Polaris Human Plus Machine Converged Equity Strategy
Add Scheme
Growth of ₹1 Crore
NARNOLIA FUSION OPPORTUNITY STRATEGY
Polaris Human Plus Machine Converged Equity Strategy
Return for the risk
3 yrs return
5%
10%
15%
NIFTY 50 Total Return Index · 9%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
2.32%
9.44%
6 Months
15.18%
2.42%
1 Year
5.18%
1.29%
3 Years
8.86%
—
5 Years
—
—
Since Inception
14.74%
23.68%
Fund Age
3 yrs 11 mo
4 mo
AUM
₹36.85 Cr
₹2.91 Cr
Alpha – 1 Year
5.53%
0.33%
Alpha – 3 Years
−0.14%
—
Information Ratio – 3 Years
0.00
—
Volatility – 1 Year
17.33%
—
Volatility – 3 Years
18.22%
—
Beta – 1 Year
0.72
—
Beta – 3 Years
0.66
—
Sharpe Ratio – 1 Year
0.08
—
Sharpe Ratio – 3 Years
0.27
—
Worst Rolling Year
8.86%
—
Value at Worst Rolling Year
₹1.09 Cr
—
Deepest Drawdown
−35.06%
—
Recovery Period
Not yet recovered
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
16.26%
—
5-Year Rolling Windows Positive
—
—
Market-Cap Mix
—
M 5% · S 92%
Number of Stocks
—
29
Portfolio P/E
—
67.46
Top 5 Holdings
—
Shilpa Medicare Ltd · 11.42%
Cash & Cash Equivalent · 7.83%
Himadri Speciality Chemical Ltd · 7.42%
Sheela Foam Ltd · 6.84%
Rubicon Research Ltd · 6.78%
Top Sectors
—
Healthcare · 31.15%
Capital Goods · 20.12%
Chemicals · 13.97%
Fixed Fee
2.50% / yr
0.50% / yr
Performance Fee / Plan
Fixed Plan
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
0% / 0% / 0%
0% / 0% / 0%
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.